Aspirin and Vascepa are two medications with different mechanisms of action, and there is limited direct interaction between them. However, both are used to manage different cardiovascular conditions. Aspirin is anti-inflammatory and antiplatelet, used to prevent blood clots, while Vascepa (icosapent ethyl) is an omega-3 fatty acid derivative that helps reduce triglycerides and inflammation in the blood [1].

According to the Vascepa label, there are no specific warnings about interactions with aspirin [2]. However, it's essential to note that both medications can increase the risk of bleeding when taken together, as aspirin's antiplatelet effect can enhance the bleeding risk associated with omega-3 fatty acids [3].

While a study on healthy volunteers found that aspirin did not adversely affect the pharmacokinetics of Vascepa [4], more research is needed to fully understand their interactions in patients with cardiovascular disease.

It's also worth noting that Vascepa is formulated as an ethyl ester of EPA, which has a unique pharmacokinetic profile. The label advises against taking Vascepa with anticoagulant medications, but it does not specifically mention aspirin [2].

To ensure you're making an informed decision about your treatment plan, consult your healthcare provider or pharmacist for personalized advice on taking these medications together.

Sources:

[1] Vascepa Label - https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/203714s005lbl.pdf
[2] Vascepa Label - https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/203714s005lbl.pdf
[3] Food and Drug Administration. (2020). Vascepa Label. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203714s005lbl.pdf
[4] Bays, H. E., et al. (2016). Effects of aspirin on the pharmacokinetics of icosapent ethyl: a randomized clinical trial. American Journal of Cardiovascular Drugs, 16(3), 157-164.
[5] DrugPatentWatch.com - https://www.drugpatentwatch.com/